Skip to content
10-K

Annual Report

TEVA PHARMACEUTICAL INDUSTRIES LIMITED TEVA TEVJF

0001193125-26-034532

← back to feed
Filed
Feb 3, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 1.16B sh
Shares Diluted FY 2025 · Dec 31, 2024 1.13B sh
Shares Diluted FY 2025 · Dec 31, 2023 1.12B sh
Shares Outstanding FY 2025 · Dec 31, 2025 1.15B sh
Operating Cash Flow FY 2025 · Dec 31, 2025 $1.65B
Operating Cash Flow FY 2025 · Dec 31, 2024 $1.25B
Operating Cash Flow FY 2025 · Dec 31, 2023 $1.37B
Cash And Equivalents FY 2025 · Dec 31, 2025 $3.56B
Cash And Equivalents FY 2025 · Dec 31, 2024 $3.3B
Cash And Equivalents FY 2025 · Dec 31, 2023 $3.23B
Stockholders Equity FY 2025 · Dec 31, 2025 $7.91B
Stockholders Equity FY 2025 · Dec 31, 2024 $5.37B
Current Liabilities FY 2025 · Dec 31, 2025 $13.46B
Current Liabilities FY 2025 · Dec 31, 2024 $12.8B
Total Liabilities FY 2025 · Dec 31, 2025 $32.83B
Total Liabilities FY 2025 · Dec 31, 2024 $33.61B
Current Assets FY 2025 · Dec 31, 2025 $13.95B
Current Assets FY 2025 · Dec 31, 2024 $12.55B
Total Assets FY 2025 · Dec 31, 2025 $40.75B
Total Assets FY 2025 · Dec 31, 2024 $39.33B
Eps Diluted FY 2025 · Dec 31, 2025 $1.21
Eps Diluted FY 2025 · Dec 31, 2024 −$1.45
Eps Diluted FY 2025 · Dec 31, 2023 −$0.50
Eps Basic FY 2025 · Dec 31, 2025 $1.23
Eps Basic FY 2025 · Dec 31, 2024 −$1.45
Eps Basic FY 2025 · Dec 31, 2023 −$0.50
Sga Expense FY 2025 · Dec 31, 2025 $1.29B
Sga Expense FY 2025 · Dec 31, 2024 $1.16B
Sga Expense FY 2025 · Dec 31, 2023 $1.16B
Net Income FY 2025 · Dec 31, 2025 $1.41B
Net Income FY 2025 · Dec 31, 2024 −$1.64B
Net Income FY 2025 · Dec 31, 2023 −$559M
Operating Income FY 2025 · Dec 31, 2025 $2.16B
Operating Income FY 2025 · Dec 31, 2024 −$303M
Operating Income FY 2025 · Dec 31, 2023 $433M
Gross Profit FY 2025 · Dec 31, 2025 $8.94B
Gross Profit FY 2025 · Dec 31, 2024 $8.06B
Gross Profit FY 2025 · Dec 31, 2023 $7.65B
Cost Of Revenue FY 2025 · Dec 31, 2025 $8.32B
Cost Of Revenue FY 2025 · Dec 31, 2024 $8.48B
Cost Of Revenue FY 2025 · Dec 31, 2023 $8.2B
Revenue FY 2025 · Dec 31, 2025 $17.26B
Revenue FY 2025 · Dec 31, 2024 $16.54B
Revenue FY 2025 · Dec 31, 2023 $15.85B